Logo
x

Search

Subscribe Now

Metastatic Colorectal Cancer

Cardiff Oncology Reports Results of Onvansertib in P-Ib/II Trial for the Treatment of KRAS-Mutated Metastatic Colorectal Cancer

Cardiff Oncology Reports Results of Onvansertib in P-Ib/II Trial for the Treatment of KRAS-Mutated Metastatic Colorectal Cancer

  • September 9, 2021
PharmaShots Interview: Cardiff Oncology's Mark Erlander Shares Insight on the P-I Data of Onvansertib for Metastatic Colorectal Cancer

PharmaShots Interview: Cardiff Oncology's Mark Erlander Shares Insight on the P-I Data of Onvansertib for Metastatic Colorectal Ca...

  • March 31, 2021
Henlius Presents Results of HLX04 (biosimilar- bevacizumab) in P-III Study at ESMO Asia 2020

Henlius Presents Results of HLX04 (biosimilar- bevacizumab) in P-III Study at ESMO Asia 2020

  • November 20, 2020
Henlius Presents P-III Data of HLX04 (biosimilar- bevacizumab) at CSCO 2020

Henlius Presents P-III Data of HLX04 (biosimilar- bevacizumab) at CSCO 2020

  • September 20, 2020
Chi-Med Initiates P-III FRESCO-2 Study of Fruquintinib in Metastatic Colorectal Cancer

Chi-Med Initiates P-III FRESCO-2 Study of Fruquintinib in Metastatic Colorectal Cancer

  • September 7, 2020
BeiGene Signs a License and Supply Agreement with Bio-Thera for BAT1706 (biosimilar- bevacizumab) in China

BeiGene Signs a License and Supply Agreement with Bio-Thera for BAT1706 (biosimilar- bevacizumab) in China

  • August 25, 2020
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.